FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4321073960> ?p ?o ?g. }

• W4321073960 endingPage "396" @default.
• W4321073960 startingPage "382" @default.
• W4321073960 abstract "Aims Cytotoxic chemotherapy is widely used in the management of pancreatic adenocarcinoma as adjuvant treatment after radical surgery and also in advanced disease. The results of randomised trials in selected patient groups provide reliable evidence of comparative treatment efficacy, but studies of population-based observational cohorts provide insight into survival outcomes in routine care. Materials and methods We conducted a large population-based observational cohort study of patients, diagnosed during 2010–2017, who received chemotherapy within the National Health Service in England. We considered overall survival and 30-day all-cause mortality risk after chemotherapy. We conducted a literature search to compare these results to published studies. Results In total, 9390 patients were included in the cohort. For 1114 patients treated with radical surgery and chemotherapy with curative intent, overall survival from the start of chemotherapy was 75.8% (95% confidence interval 73.3–78.3) at 1 year and 22.0% (18.6–25.3) at 5 years. For 7468 patients treated with non-curative intent, overall survival was 29.6% (28.6–30.6) at 1 year and 2.0% (1.6–2.4) at 5 years. In both groups, poorer performance status at the start of chemotherapy was strongly associated with poorer survival. The risk of 30-day mortality in patients treated with non-curative intent was 13.6% (12.8–14.5). This was higher in younger patients and those with higher stage disease and a poorer performance status. Conclusions Survival in this general population was poorer than that published in randomised trials. This study will aid informed discussion with patients regarding anticipated outcomes in routine clinical care." @default.
• W4321073960 created "2023-02-17" @default.
• W4321073960 creator A5002979606 @default.
• W4321073960 creator A5052476826 @default.
• W4321073960 creator A5085866945 @default.
• W4321073960 creator A5089961001 @default.
• W4321073960 date "2023-06-01" @default.
• W4321073960 modified "2023-09-27" @default.
• W4321073960 title "Cytotoxic Chemotherapy for Pancreatic Adenocarcinoma in England 2010–2017: Survival Outcomes" @default.
• W4321073960 cites W2066801367 @default.
• W4321073960 cites W2157590016 @default.
• W4321073960 cites W2412717755 @default.
• W4321073960 cites W2507375366 @default.
• W4321073960 cites W2581973599 @default.
• W4321073960 cites W2940683302 @default.
• W4321073960 cites W2963698953 @default.
• W4321073960 cites W4211253487 @default.
• W4321073960 cites W4294001741 @default.
• W4321073960 doi "https://doi.org/10.1016/j.clon.2023.02.007" @default.
• W4321073960 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36948915" @default.
• W4321073960 hasPublicationYear "2023" @default.
• W4321073960 type Work @default.
• W4321073960 citedByCount "0" @default.
• W4321073960 crossrefType "journal-article" @default.
• W4321073960 hasAuthorship W4321073960A5002979606 @default.
• W4321073960 hasAuthorship W4321073960A5052476826 @default.
• W4321073960 hasAuthorship W4321073960A5085866945 @default.
• W4321073960 hasAuthorship W4321073960A5089961001 @default.
• W4321073960 hasConcept C126322002 @default.
• W4321073960 hasConcept C141071460 @default.
• W4321073960 hasConcept C201903717 @default.
• W4321073960 hasConcept C23131810 @default.
• W4321073960 hasConcept C2776694085 @default.
• W4321073960 hasConcept C2908647359 @default.
• W4321073960 hasConcept C71924100 @default.
• W4321073960 hasConcept C72563966 @default.
• W4321073960 hasConcept C99454951 @default.
• W4321073960 hasConceptScore W4321073960C126322002 @default.
• W4321073960 hasConceptScore W4321073960C141071460 @default.
• W4321073960 hasConceptScore W4321073960C201903717 @default.
• W4321073960 hasConceptScore W4321073960C23131810 @default.
• W4321073960 hasConceptScore W4321073960C2776694085 @default.
• W4321073960 hasConceptScore W4321073960C2908647359 @default.
• W4321073960 hasConceptScore W4321073960C71924100 @default.
• W4321073960 hasConceptScore W4321073960C72563966 @default.
• W4321073960 hasConceptScore W4321073960C99454951 @default.
• W4321073960 hasFunder F4320319985 @default.
• W4321073960 hasFunder F4320320290 @default.
• W4321073960 hasIssue "6" @default.
• W4321073960 hasLocation W43210739601 @default.
• W4321073960 hasLocation W43210739602 @default.
• W4321073960 hasOpenAccess W4321073960 @default.
• W4321073960 hasPrimaryLocation W43210739601 @default.
• W4321073960 hasRelatedWork W2003938723 @default.
• W4321073960 hasRelatedWork W2047967234 @default.
• W4321073960 hasRelatedWork W2118496982 @default.
• W4321073960 hasRelatedWork W2439875401 @default.
• W4321073960 hasRelatedWork W2603773853 @default.
• W4321073960 hasRelatedWork W3099665691 @default.
• W4321073960 hasRelatedWork W3120510923 @default.
• W4321073960 hasRelatedWork W4238867864 @default.
• W4321073960 hasRelatedWork W45151993 @default.
• W4321073960 hasRelatedWork W2525756941 @default.
• W4321073960 hasVolume "35" @default.
• W4321073960 isParatext "false" @default.
• W4321073960 isRetracted "false" @default.
• W4321073960 workType "article" @default.